|
1
|
Hartupee JC, Zhang H, Bonaldo MF, Soares
MB and Dieckgraefe BK: Isolation and characterization of a cDNA
encoding a novel member of the human regenerating protein family:
Reg IV. Biochim Biophys Acta. 1518:287–293. 2001. View Article : Google Scholar
|
|
2
|
Oue N, Hamai Y, Mitani Y, Matsumura S,
Oshimo Y, Aung PP, Kuraoka K, Nakayama H and Yasui W: Gene
expression profile of gastric carcinoma: identification of genes
and tags potentially involved in invasion, metastasis, and
carcinogenesis by serial analysis of gene expression. Cancer Res.
64:2397–2405. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aung PP, Oue N, Mitani Y, Nakayama H,
Yoshida K, Noguchi T, Bosserhoff AK and Yasui W: Systematic search
for gastric cancer-specific genes based on SAGE data: melanoma
inhibitory activity and matrix metalloproteinase-10 are novel
prognostic factors in patients with gastric cancer. Oncogene.
25:2546–2557. 2006. View Article : Google Scholar
|
|
4
|
Oue N, Mitani Y, Aung PP, Sakakura C,
Takeshima Y, Kaneko M, Noguchi T, Nakayama H and Yasui W:
Expression and localization of Reg IV in human neoplastic and
non-neoplastic tissues: Reg IV expression is associated with
intestinal and neuroendocrine differentiation in gastric
adenocarcinoma. J Pathol. 207:185–198. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takehara A, Eguchi H, Ohigashi H, Ishikawa
O, Kasugai T, Hosokawa M, Katagiri T, Nakamura Y and Nakagawa H:
Novel tumor marker REG4 detected in serum of patients with
resectable pancreatic cancer and feasibility for antibody therapy
targeting REG4. Cancer Sci. 97:1191–1197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakata K, Nagai E, Ohuchida K, Aishima S,
Hayashi A, Miyasaka Y, Yu J, Mizumoto K, Tanaka M and Tsuneyoshi M:
REG4 is associated with carcinogenesis in the ‘intestinal’ pathway
of intraductal papillary mucinous neoplasms. Mod Pathol.
22:460–468. 2009.
|
|
7
|
Oue N, Kuniyasu H, Noguchi T, Sentani K,
Ito M, Tanaka S, Setoyama T, Sakakura C, Natsugoe S and Yasui W:
Serum concentration of Reg IV in patients with colorectal cancer:
overexpression and high serum levels of Reg IV are associated with
liver metastasis. Oncology. 72:371–380. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohara S, Oue N, Matsubara A, Mita K,
Hasegawa Y, Hayashi T, Usui T, Amatya VJ, Takeshima Y, Kuniyasu H
and Yasui W: Reg IV is an independent prognostic factor for relapse
in patients with clinically localized prostate cancer. Cancer Sci.
99:1570–1577. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sasahira T, Oue N, Kirita T, Luo Y, Bhawal
UK, Fujii K, Yasui W and Kuniyasu H: Reg IV expression is
associated with cell growth and prognosis of adenoid cystic
carcinoma in the salivary gland. Histopathology. 53:667–675. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hayashi T, Matsubara A, Ohara S, Mita K,
Hasegawa Y, Usui T, Arihiro K, Norimura S, Sentani K, Oue N and
Yasui W: Immunohistochemical analysis of Reg IV in urogenital
organs: Frequent expression of Reg IV in prostate cancer and
potential utility as serum tumor marker. Oncol Rep. 21:95–100.
2009.
|
|
11
|
Tamura H, Ohtsuka M, Washiro M, Kimura F,
Shimizu H, Yoshidome H, Kato A, Seki N and Miyazaki M: Reg IV
expression and clinicopathologic features of gallbladder carcinoma.
Hum Pathol. 40:1686–1692. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sentani K, Oue N, Tashiro T, Sakamoto N,
Nishisaka T, Fukuhara T, Taniyama K, Matsuura H, Arihiro K, Ochiai
A and Yasui W: Immunohistochemical staining of Reg IV and
claudin-18 is useful in the diagnosis of gastrointestinal signet
ring cell carcinoma. Am J Surg Pathol. 32:1182–1189. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sentani K, Oue N, Noguchi T, Sakamoto N,
Matsusaki K and Yasui W: Immunostaining of gastric cancer with
neuroendocrine differentiation: Reg IV-positive neuroendocrine
cells are associated with gastrin, serotonin, pancreatic
polypeptide and somatostatin. Pathol Int. 60:291–297. 2010.
View Article : Google Scholar
|
|
14
|
Heiskala K, Arola J, Heiskala M and
Andersson LC: Expression of Reg IV and Hath1 in neuroendocrine
neoplasms. Histol Histopathol. 25:63–72. 2010.PubMed/NCBI
|
|
15
|
Mitani Y, Oue N, Matsumura S, Yoshida K,
Noguchi T, Ito M, Tanaka S, Kuniyasu H, Kamata N and Yasui W: Reg
IV is a serum biomarker for gastric cancer patients and predicts
response to 5-fluorouracil-based chemotherapy. Oncogene.
26:4383–4393. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kondo T, Oue N, Yoshida K, Mitani Y, Naka
K, Nakayama H and Yasui W: Expression of POT1 is associated with
tumor stage and telomere length in gastric carcinoma. Cancer Res.
64:523–529. 2004. View Article : Google Scholar : PubMed/NCBI
|
